ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.08% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD | ||
| 1024 |  RGEN Repligen Corporation - Common Stock | 144.88 USD | +0.44% | +0.21% | +8.35% | -12.56% | 8.17 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +7.76% | -1.00% | 8.00 B USD | ||
| 1035 |  ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1036 |  BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 297.56 USD | +0.48% | -0.36% | +2.96% | -11.62% | 7.96 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.69% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.65% | +69.74% | 7.26 B USD | ||
| 1120 |  LNTH Lantheus Holdings, Inc. - Common Stock | 105.39 USD | -0.24% | +3.83% | +0.59% | +88.00% | 6.86 B USD | ||
| 1122 |  PACS PACS Group, Inc. Common Stock | 43.29 USD | +0.12% | -4.12% | +16.59% | +236.89% | 6.85 B USD | ||
| 1156 |  SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1161 |  CHE Chemed Corp | 492.28 USD | +0.80% | +1.43% | +17.61% | +6.45% | 6.53 B USD | ||
| 1176 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.46 USD | -3.63% | -6.12% | +12.16% | +139.06% | 6.40 B USD |
ニュース ヘルスケア株
BATTMANからROBBINへ優先順位が移行し、アジェナスの株価が100%超急騰
ユナイテッドヘルス・ウォッチ：弱気なチャートパターン、第2四半期決算の重要性を高める
暗号市場はまちまち、NFTセクターは4%超上昇、SocialFiセクターは2%近く下落
「LABの仕手筋」が2日間でAsterに1850万枚のLABを送金、価格が53%下落
独占：バークシャーによるアルファベットとユナイテッドヘルスへの投資は、グレッグ・アベルCEOが投資戦略の幅を広げていることを示していると専門家が指摘
インテルの株価は倍増したのに、なぜJPモルガンは同社を「空売りの有力候補」と見なしているのか？
LABチームが1000万枚のLABを焼却、約1130万ドル相当
Gainers ヘルスケア株
 XAIR Beyond Air, Inc. - Common Stock | 7.49 | +1683.33% |
 QTTB Q32 Bio Inc. - Common Stock | 21.38 | +90.72% |
 AGEN Agenus Inc. - Common Stock | 6.12 | +82.69% |
 SRXH SRX Health Solutions, Inc. Common Stock | 2.78 | +31.13% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 | +23.97% |
 TOIIW The Oncology Institute, Inc. - Warrant | 0.0597 | +19.64% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 | +19.50% |
 GALT Galectin Therapeutics Inc. - Common Stock | 4.60 | +13.30% |
Losers ヘルスケア株
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.49 | -33.78% |
 AEON AEON Biopharma, Inc. Class A Common Stock | 0.32 | -33.33% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0537 | -29.34% |
 BIVI BioVie Inc. - Common stock | 1.64 | -27.75% |
 ZCMD Zhongchao Inc. - Class A Ordinary Shares | 1.51 | -25.62% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 14.21 | -25.01% |
 HUMAW Humacyte, Inc. - Warrant | 0.0076 | -24.00% |
 AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 | -21.58% |